This 2020 electron microscope image provided by the National Institute of Allergy and Infectious Diseases - Rocky Mountain Laboratories shows SARS-CoV-2 virus particles which cause COVID-19, isolated from a patient in the U.S., emerging from the surface of cells cultured in a lab. According to a study released in The Lancet Global Health on Wednesday, Oct. 27, 2021, Fluvoxamine, a cheap antidepressant, reduced the need for hospitalization among high-risk adults with COVID-19. (NIAID-RML via AP)
By Carla K. Johnson
A cheap antidepressant reduced the need for hospitalization among high-risk adults with COVID-19 in a study hunting for existing drugs that could be repurposed to treat coronavirus.
Researchers tested the pill used for depression and obsessive-compulsive disorder because it was known to reduce inflammation and looked promising in smaller studies.
They've shared the results with the U.S. National Institutes of Health, which publishes treatment guidelines, and they hope for a World Health Organization recommendation.
“If WHO recommends this, you will see it widely taken up,” said study co-author Dr. Edward Mills of McMaster University in Hamilton, Ontario, adding that many poor nations have the drug readily available. “We hope it will lead to a lot of lives saved.”
The pill, called fluvoxamine, would cost $4 for a course of COVID-19 treatment. By comparison, antibody IV treatments cost about $2,000 and Merck's experimental antiviral pill for COVID-19 is about $700 per course. Some experts predict various treatments eventually will be used in combination to fight the coronavirus.
Researchers tested the antidepressant in nearly 1,500 Brazilians recently infected with coronavirus who were at risk of severe illness because of other health problems, such as diabetes. About half took the antidepressant at home for 10 days, the rest got dummy pills. They were tracked for four weeks to see who landed in the hospital or spent extended time in an emergency room when hospitals were full.
In the group that took the drug, 11% needed hospitalization or an extended ER stay, compared to 16% of those on dummy pills.
The results, published Wednesday in the journal Lancet Global Health, were so strong that independent experts monitoring the study recommended stopping it early because the results were clear.
Questions remain about the best dosing, whether lower risk patients might also benefit and whether the pill should be combined with other treatments.
The larger project looked at eight existing drugs to see if they could work against the pandemic virus. The project is still testing a hepatitis drug, but all the others — including metformin, hydroxychloroquine and ivermectin — haven't panned out.
The cheap generic and Merck's COVID-19 pill work in different ways and “may be complementary,” said Dr. Paul Sax of Brigham and Women’s Hospital and Harvard Medical School, who was not involved in the study. Earlier this month, Merck asked regulators in the U.S. and Europe to authorize its antiviral pill.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.
The 2022 County Health Rankings largely found that the pandemic worsened the burdens faced by women, people of color, and in low income brackets. Cheddar News speaks with Sheri Johnson, co-director of County Health Rankings and Roadmaps who breaks down the details.
With National Infertility Awareness Week underway, the fertility and family-building benefits provider for employers, Kindbody, is looking to make a full suite of treatments and care accessible — including for LGBTQ+ patients. Founder and chairwoman Gina Bartasi joined Cheddar's Opening Bell to talk about the importance of infertility awareness, what role employers play in offering benefits, and how to remove the stigma around the fertility conversation. "We have to talk about the patient holistically, not just fertility services, but what can we do from a mental health standpoint to support patients," she said. "Most patients talk about fertility being more stressful than divorce, infertility being more prevalent than cancer or diabetes. So it is our mission, remains our mission, to elevate awareness around infertility, not just [during] National Infertility Awareness Week."
New York City’s geography makes it particularly at risk to the impacts of climate change - like rising seas and subsequent flooding. The city has already experienced the effects of increasingly severe weather. In response, the city is building a plan to protect itself, from flood walls, to levees, to redesigning its coast.
With mask mandates lifted across various parts of the country, healthy indoor air quality in public spaces is more crucial than ever before. According to the CDC, proper ventilation, in addition to other preventative measures, is instrumental to preventing the rapid spread of covid-19 indoors. As the push for higher air quality ramps up, AtmosAir is providing a high-tech solution for cleaner, greener air indoors. Steve Levine, CEO, AtmosAir, joined Cheddar’s Opening Bell to discuss.
Catching you up on what you need to know on April 27, 2022, with Tesla stocks absorbing an initial hit following Elon Musk's purchase of Twitter, Russia pausing its natural gas supplies to Poland and Bulgaria, NASA's SpaceX Crew-4 mission taking off, and more.
New Mexico is under a state of emergency after flames scorched across 84 square miles. Strong winds fueled 20 wildfires, destroying hundreds of buildings in the state this weekend. New Mexico is just one of several states across the southwest facing severe wildfires. James McMullen, retired California state fire marshal and forensic fire expert, joins Cheddar News to discuss.
SpoonTEK is an eating utensil that uses new technology to enhance flavors. Co-founders Ken and Cameron Davidov join Cheddar News to explain how the high-tech silverware can not only boost taste but also the health of its user.
Tim Brown, research professor at Desert Research Institute and director at the Western Regional Climate Center, joins Cheddar News to discuss the environmental impact of recent wildfires.
Vice President Kamala Harris tested positive for COVID-19 on Tuesday, the White House announced. That's underscoring the persistence of the highly contagious virus even as the U.S. eases restrictions in a bid to revert to pre-pandemic normalcy.
